TDP-43 proteins

Mayo Clinic Breakthrough With ALS Treatment In Mice

Medicine & Technology Researchers at the Jacksonville, Florida Mayo Clinic have gained a mouse model for testing potential amyotrophic lateral sclerosis (ALS) treatments. ALS or Lou Gehrig's disease is associated with various behavioral features and neuropathological symptoms as is frontotemporal dementia (FTD); both are caused by a mutation in the C9ORF72 gene. Both result in the death of neurons in the spinal cord and brain, which leads to inability to control muscles, paralysis, and death.

Recommended Stories

Real Time Analytics